Solabegron

DRUG2 trials

Sponsors

GlaxoSmithKline

Conditions

Overactive Bladder

Phase 1

A Two-Part Study to Determine: Best Medication Formulation and Food Effect

CompletedNCT00427596

GlaxoSmithKlineOveractive Bladder

Start: 2007-01-31End: 2007-08-31Updated: 2008-10-07

Phase 2

Dose Ranging Study Of Solabegron Versus Placebo In Female Patients With Overactive Bladder Symptoms

CompletedNCT00343486

GlaxoSmithKlineOveractive Bladder

Start: 2006-05-31Target: 240Updated: 2009-05-18